COPENHAGEN — The pandemic has blocked Novak Djokovic’s march to tennis heritage, so the 34-year-previous might be pinning his hopes on a cure for COVID to get his hands on yet another glorious grand slam right before time operates out.
The Serbian celebrity, who became a target of the global vaccine discussion about his failed attempt to enter Australia devoid of becoming inoculated, retains a majority stake in a Danish biotech company aiming to build a therapy to counter COVID-19, the company’s CEO informed Reuters.
QuantBioRes boss Ivan Loncarevic, who described himself as an entrepreneur, said the tennis player’s acquisition of the 80 per cent stake was built in June 2020 but declined to say how a lot it was.
The enterprise is developing a peptide, which inhibits the coronavirus from infecting the human mobile, expects to start medical trials in Britain this summer, according to Loncarevic, who stressed the business was doing the job on a treatment method, not a vaccine.
The CEO explained the firm experienced about a dozen scientists doing the job in Denmark, Australia and Slovenia. In accordance to the Danish company sign-up, Djokovic and his wife Jelena have 40.8% and 39.2 % of the company, respectively.
A spokesperson for Djokovic did not promptly react to a ask for for remark.
Djokovic has liked phenomenal accomplishment — Forbes listed him in the world’s prime-50 maximum paid out athletes for 2021. It calculated his on-court docket earnings at $4.5 million, dwarfed by the $30 million it explained he acquired off court.
But time may possibly not be on the planet range one’s side in his quest to be viewed as the biggest player is heritage, as he innovations deeper into his 30s.
He had desperately hoped to participate in in Australian Open this thirty day period with his sights firmly set on netting a 21st grand slam title, which would go him over archrivals Roger Federer and Rafael Nadal.
Discouraged Djokovic now challenges being frozen out of tennis, with rules on tourists who are unvaccinated tightening in the 3rd year of the pandemic and some tournaments reconsidering exemptions.
The most immediate issue is the next grand slam — the French Open in May perhaps where by Nadal has previously amassed a staggering 13 titles — following the country’s sporting activities ministry said on Monday there would be no exemption from a new vaccine move law.